Cellular glucose transport disturbances as a marker of the pre-diabetic state - Pathogenetic and clinical significance of the assessment of GLUT4 expression

Endokrynologia Polska

Volumn 61, Issue 3, 2010, Pages 269-274

  Bernat Karpińska, Małgorzata ^a   Czech, Anna ^a   Pia̧tkiewicz, Paweł ^a   Wierzbicki, Piotr ^b   Górski, Andrzej ^b  

^a Brodnowski Hospital Warsaw   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Glucose transport; GLUT; Lymphocytes; Prediabetes; Type 2 diabetes

Indexed keywords

GLUCOSE TRANSPORTER 4;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HUMAN; IMMUNOFLUORESCENCE; IMPAIRED GLUCOSE TOLERANCE; LYMPHOCYTE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; QUANTITATIVE ANALYSIS; RISK ASSESSMENT;

ADULT; AGED; BIOLOGICAL MARKERS; BIOLOGICAL TRANSPORT; DIABETES MELLITUS, TYPE 2; EARLY DIAGNOSIS; FEMALE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; PREDIABETIC STATE;

EID: 77955601605     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Joost HG, Thorens B. The extended GLUT family of sugar/polyol transport facilitators: nomenclature, sequence characteristics and potential function of its novel members. Mol Membr Biol 2001; 18: 247-256.
2. Saier MH Jr. Families of transmembrane sugar transport proteins. Mol Microbiol 2000; 35: 699-710. (Pubitemid 30107522)
3. Saier MH Jr. A functional-phylogenetic classification system for transmembrane solute transport proteins. Microbiol Mol Biol Rev 2000; 64: 354-411.
4. Phay JE, Hussain HB, Moley JF. Strategy for identification of novel glucose transporter family members by using internet-based genomic data-bases. Surgery 2000; 128: 946-951.
5. Joost HG, Bell GI, Best JD et al. Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators. Am J Physiol Endocrinol Metab 2002; 282: E 974-E 986.
6. McVie-Wylie AJ, Lamson DR, Chen YT. Molecular cloning of a novel member of the GLUT family of transporter, SLC2a10 (GLUT10), localized on chromosome 20q13.1: a candidate gene for NIDDM susceptibility. Genomics 2001; 72: 113-117.
7. Phay JE, Hussain HB, Moley JF Cloning and expression analysis of a novel member of the facilitative glucose transporter family, SLC2A9 (GLUT9). Genomics 2000; 66: 217-220.
8. Reagan LP, Gorovits N, Hoskin EK et al. Localization and regulation of GLUT 1 glucose transporter in the hippocampus of streptozotocin diabetic rats. Proc Natl Acad Sci USA 2001; 98: 2820-2825.
9. Shikman AR, Brinson DC, Valbracht J et al. Cytokine regulation of facilitated glucose transport in human articular chondrocytes. J Immunol 2001; 167: 7001-7008. (Pubitemid 33144195)
10. Korgun ET, Demir R, Sedlmayr P et al. Sustained hypoglycemia affects glucose transporter expression of human blood leukocytes. Blood Cells Mol Dis 2002; 28: 152-159.
11. Estrada DE, Elliott E, Zinman B et al. Regulation of glucose transport and expression of GLUT3 transporters in human circulating mononuclear cells: studies in cells from insulin-dependent diabetic and nondiabetic individuals. Metabolism 1994; 43: 591-598.
12. Daneman D, Zinman B, Elliott ME et al. Insulin-stimulated glucose transport in circulating mononuclear cells from nondiabetic and IDDM subjects. Diabetes 1992; 41: 227-234.
13. Pia̧tkiewicz P, Kłosowska D, Czech A et al. Investigations of Glucotransporter 4 (GLUT4) expression in lymphocytes of healthy subjects and type 2 diabetic patients. Med Metabol 2006; 3: 16-18.
14. Fu J, Miami L, Melbert BR et al. Facilitative glucose transporter gene expression in human lymphocytes, monocytes and macrophages: a role for GLUT isoform 1,3 and 5 in the immune response and foam cell formation. Blood Cells Mol Dis 2004; 32: 182-190.
15. Pia̧tkiewicz P, Czech A, Tatoń J. Glucose transport in human peripheral blood lymphocytes influence by type 2 diabetes mellitus. Arch Immunol Ther Exp 2007; 55: 119-126. (Pubitemid 46559202)
16. Carayannopoulos MO, Chi MM, Cui Y et al. GLUT 8 is a glucose transporter responsible for insulin-stimulated glucose up-take in the blastocyst. Proc Natl Acad Sci USA 2000; 97: 7313-7318.
17. Doege H, Schurmann A, Bahrenberg G et al. GLUT8, a novel member of the sugar transport facilitator family with glucose transport activity. J Biol Chem 2000; 275: 16275-16280. (Pubitemid 30366941)
18. Doege H, Bocianski A, Joost HG et al. Activity and genomic organization of human glucose transporter 9 (GLUT9), a novel member of the family of sugar-transport facilitators predominantly expressed in brain and leucocytes. Biochem J. 2000; 350: 771-776.
19. Watson RT, Pessin JE. Intracellular organization of insulin signaling and GLUT4 translocation. Recent Prog Horm Res 2001; 49: 175-193.
20. Benomar Y, Natur N, Aubourg A et al. Insulin and leptin induce GLUT4 plasma membrane translocation and glucose uptake in a human neuronal cell line by phosphatidylinositol 3-kinase-dependent mechanism. Endocrinology 2006; 147: 2550-2556.
21. Szablewski L, Pia̧tkiewicz P, Oleszczak B et al. Wpływ leczenia insulina̧ chorych na cukrzycȩ typu 2 na pobieranie deoksy-D-glukozy przez limfocyty krwi obwodowej. Diab Dośw Klin 2004; 4, 3: 217-223.
22. Strus A, Szepietowska B, Zonenberg A et al. Możliwości prewencji cukrzycy typu 2. Pol J Endocrinol 2008; 59: 6-12.
23. Stelmachowska-Banaś M, Zdunowski P, Zgliczyński W. Abnormalities in glucose homeostasis in acromegaly. Does the prevalence of glucose intolerance depend on the level of activity of the disease and the duration of the symptoms? Pol J Endocrinol 2009; 60: 20-24.
24. Levitan EB, Song Y, Ford ES et al. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med 2004; 164: 2147-2155. (Pubitemid 39410805)
25. Harris M. Frequency of oral glucose tolerance testing in US. Diabetes Care 1995; 18: 134-136.
26. Siewko K, Szelachowska M, Popławska-Kita A et al. Peptyd C jako czynnik ryzyka rozwoju cukrzycy typu 1 u krewnych I stopnia osób chorych na cukrzycȩ autoimmunologiczna̧. Pol J Endocrinol 2009; 60: 357-362.
27. Nowak M, Wielkoszyński T, Marek B et al. A comparison of the levels of hepatocyte growth factor in serum in patients with type 1 diabetes mellitus with different stages of diabetic retinopathy. Pol J Endocrinol 2008; 59: 2-5.
28. Szablewski L, Sobczyk-Kopcioł A, Oleszczak B et al. GLUT4 is expressed in circulating lymphocytes of diabetic patients. A method to detect early prediabetic stages? Diabetologia Croat 2007; 36: 69-76.
29. James DE, Piper RC. Insulin resistance, diabetes and the insulin-regulated trafficking. J Cell Biol 1994; 126: 1123-1126. (Pubitemid 24266544)
30. La Vecchia C, Negri E, Decarli A et al. Diabetes mellitus and the risk of primary liver cancer. Int J Cancer 1997; 73: 204-207. (Pubitemid 27448819)
31. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005; 97: 1679-1687. (Pubitemid 41672234)
32. Rousseau MC, Parent ME, Pollak MN et al. Diabetes mellitus and cancer risk in a population - based case - control study among men from Montreal, Canada. Int J Cancer 2006; 118: 2105-2109.
33. Chang FY, Shaio MF. Decreased cell-mediated immunity in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1995; 28: 137-146.
34. Nassaji-Zavareh M, Taheri R, Ghorbani R et al. Undiagnosed diabetes mellitus in patients with herpes zoster. Indian J Dermatol 2008; 53: 119-121.